Category: Clinical Trials
Preventing Malaria: A Glimmer of Hope?
A recent clinical trial tested a new approach to malaria prevention involving monoclonal antibodies.
FDA’s Decision to Approve Aduhelm (aducanumab) for Alzheimer’s
Criticism of the FDA's decision to approve aducanumab for Alzheimer's disease.
Ivermectin is the new hydroxychloroquine, take 3: Conspiracy theories vs. science
Last month, I discussed why ivermectin is the new hydroxychloroquine:, basically a “miracle cure” that isn’t. Since then, conspiracy theories about its being "suppressed" have continued to bump heads with the science showing that, at the very best, evidence for its efficacy is very weak and, at the worst, the drug is useless.
Abigail Shrier’s Irreversible Damage: A Wealth of Irreversible Misinformation
A critical, science-based analysis of Abigail Shrier's book Irreversible Damage.
Ivermectin is the new hydroxychloroquine, take 2
A few months ago, Scott Gavura wrote about how the veterinary deworming drug ivermectin has become the new hydroxychloroquine in that it is being promoted as a highly effective treatment against COVID-19—and by many of the same people who previously promoted HCQ—despite evidence that is, at best very weak and at worst completely negative. Unfortunately, with the publication of two new and...
No evidence, no problem: A closer look at the aducanumab approval
Why did the FDA approve aducanumab, a drug that hasn't been shown to work?
A Blood Test for Fibromyalgia?
The FM/a test is advertised as a definitive test to diagnose fibromyalgia. It isn't definitive. It is expensive. It has not been shown to change patient outcomes.
Eye Drops for Dry Eyes
I could have chosen a prescription eye drop for my dry eyes. I decided not to. Here's why.

